The editorial process of EJNMMI Reports does not judge on research significance. All valid research including longer and brief reports, negative and positive results, data & protocol descriptors will be considered, see formats considered below. The journal does also meet international research integrity standards.
EJNMMI Reports publishes scientific articles that are of interest to the nuclear medicine and molecular imaging community and cover diagnostics and therapy within all subfields in this subject area. The journal aims at providing clinical as well as scientific information that is useful for all relevant imaging and clinical communities as well as allied professions.
The journal considers various article types like original research articles, brief communications on novel preliminary approaches, reports on originals, case reports, pictorial essays, reviews and educational material, guidelines published by experts from different clinical and research disciplines, editorials, and letters to the editor.
Announcement
Since January 2024: European Journal of Hybrid Imaging is now EJNMMI Reports
and has a new Editor-in-Chief - Prof. Dr. Ignasi Carriò Gasset, Autonomous University of Barcelona, Spain
2022 Citation Impact
1.7 - 2-year Impact Factor
1.8 - 5-year Impact Factor
0.635 - SNIP (Source Normalized Impact per Paper)
0.453 - SJR (SCImago Journal Rank)
2023 Speed
3 days submission to first editorial decision for all manuscripts (Median)
43 days submission to accept (Median)
2023 Usage
205,903 downloads
29 Altmetric mentions
